• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    PDI, Inc. (PDII)

    -NasdaqGM
    1.42 Down 0.01(0.70%) Jul 2, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    PDI, Inc.
    Morris Corporate Center 1
    Building A
    Parsippany, NJ 07054
    United States - Map
    Phone: 862-207-7800
    Website: http://www.pdi-inc.com

    Details 
    Index Membership:N/A
    Sector:Services
    Industry:Business Services
    Full Time Employees:775

    Business Summary 

    PDI, Inc. provides outsourced commercial services to pharmaceutical, biotechnology, diagnostics, and healthcare companies in the United States. It operates in two segments, Commercial Services and Interpace Diagnostics. The Commercial Services segment offers outsourced sales teams that target healthcare providers, providing a range of complementary sales support services designed to achieve its customers' strategic and financial product objectives. This segment offers a range of personal and non-personal promotional options for the commercialization of their products throughout the product lifecycles, from development through maturity. It also provides other promotional services, including clinical educator, teledetailing, and full product commercialization services. This segment’s services include product distribution, personal and non-personal product detailing, full supply chain management, operations, sales, marketing, compliance, and regulatory/medical management. The Interpace Diagnostics segment focuses on developing and commercializing molecular diagnostic tests for physicians and patients with diagnostic options for detecting genetic and other molecular alterations associated with gastrointestinal and endocrine cancers. This segment offers PancraGen, a diagnostic test designed for determining risk of malignancy in pancreatic cysts; and ThyGenX, a next-generation sequencing test designed to assist physicians in distinguishing between benign and malignant genotypes in indeterminate thyroid nodules. It also has three diagnostic tests in late stage development that are designed to detect genetic alterations that are associated with gastrointestinal cancers; and one diagnostic test in late stage development that is designed to detect genetic alterations that are associated with endocrine cancers. PDI, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on PDI, Inc.

    Corporate Governance 
    PDI, Inc.’s ISS Governance QuickScore as of Jul 1, 2013 is 4. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 7; Compensation: 4.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Ms. Nancy S. Lurker , 57
    Chief Exec. Officer and Director
    776.00K0.00
    Mr. Graham G. Miao M.S., M.B.A., Ph.D., 51
    Chief Financial Officer, Exec. VP and Treasurer
    86.00K0.00
    Mr. Gerald R. Melillo Jr., 54
    Pres of Sales Services
    418.00K0.00
    Mr. Jade L. Shields Sr.,
    Sr. VP of Corp. Compliance & Ethics
    N/AN/A
    Ms. Amy Lombardi ,
    Exec. Director of Marketing
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders